Literature DB >> 21454652

SEL1L protein critically determines the stability of the HRD1-SEL1L endoplasmic reticulum-associated degradation (ERAD) complex to optimize the degradation kinetics of ERAD substrates.

Yasutaka Iida1, Tsutomu Fujimori, Katsuya Okawa, Kazuhiro Nagata, Ikuo Wada, Nobuko Hosokawa.   

Abstract

The mammalian HRD1-SEL1L complex provides a scaffold for endoplasmic reticulum (ER)-associated degradation (ERAD), thereby connecting luminal substrates for ubiquitination at the cytoplasmic surface after their retrotranslocation through the endoplasmic reticulum membrane. In this study the stability of the mammalian HRD1-SEL1L complex was assessed by performing siRNA-mediated knockdown of each of its components. Although endogenous SEL1L is a long-lived protein, the half-life of SEL1L was greatly reduced when HRD1 is silenced. Conversely, transiently expressed SEL1L was rapidly degraded but was stabilized when HRD1 was coexpressed. This was in contrast to the yeast Hrd1p-Hrd3p, where Hrd1p is destabilized by the depletion of Hrd3p, the SEL1L homologue. Endogenous HRD1-SEL1L formed a large ERAD complex (Complex I) associating with numerous ERAD components including ERAD lectin OS-9, membrane-spanning Derlin-1/2, VIMP, and Herp, whereas transiently expressed HRD1-SEL1L formed a smaller complex (Complex II) that was associated with OS-9 but not with Derlin-1/2, VIMP, or Herp. Despite its lack of stable association with the latter components, Complex II supported the retrotranslocation and degradation of model ERAD substrates α1-antitrypsin null Hong-Kong (NHK) and its variant NHK-QQQ lacking the N-glycosylation sites. NHK-QQQ was rapidly degraded when SEL1L was transiently expressed, whereas the simultaneous transfection of HRD1 diminished that effect. SEL1L unassociated with HRD1 was degraded by the ubiquitin-proteasome pathway, which suggests the involvement of a ubiquitin-ligase other than HRD1 in the rapid degradation of both SEL1L and NHK-QQQ. These results indicate that the regulation of the stability and assembly of the HRD1-SEL1L complex is critical to optimize the degradation kinetics of ERAD substrates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454652      PMCID: PMC3089536          DOI: 10.1074/jbc.M110.215871

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins.

Authors:  Pedro Carvalho; Veit Goder; Tom A Rapoport
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

2.  Simultaneous induction of the four subunits of the TRAP complex by ER stress accelerates ER degradation.

Authors:  Koji Nagasawa; Toshio Higashi; Nobuko Hosokawa; Randal J Kaufman; Kazuhiro Nagata
Journal:  EMBO Rep       Date:  2007-03-23       Impact factor: 8.807

3.  Characterization of an ERAD pathway for nonglycosylated BiP substrates, which require Herp.

Authors:  Yuki Okuda-Shimizu; Linda M Hendershot
Journal:  Mol Cell       Date:  2007-11-30       Impact factor: 17.970

4.  SEL1L and HRD1 are involved in the degradation of unassembled secretory Ig-mu chains.

Authors:  Monica Cattaneo; Mieko Otsu; Claudio Fagioli; Simone Martino; Lavinia Vittoria Lotti; Roberto Sitia; Ida Biunno
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

5.  A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.

Authors:  Tomohiro Omura; Masayuki Kaneko; Yasunobu Okuma; Yasuko Orba; Kazuo Nagashima; Ryosuke Takahashi; Noboru Fujitani; Satoshi Matsumura; Akihisa Hata; Kyoko Kubota; Karin Murahashi; Takashi Uehara; Yasuyuki Nomura
Journal:  J Neurochem       Date:  2006-10-24       Impact factor: 5.372

Review 6.  The role of MRH domain-containing lectins in ERAD.

Authors:  Nobuko Hosokawa; Yukiko Kamiya; Koichi Kato
Journal:  Glycobiology       Date:  2010-01-28       Impact factor: 4.313

7.  Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508.

Authors:  Daisuke Morito; Kazuyoshi Hirao; Yukako Oda; Nobuko Hosokawa; Fuminori Tokunaga; Douglas M Cyr; Keiji Tanaka; Kazuhiro Iwai; Kazuhiro Nagata
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

8.  OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD.

Authors:  John C Christianson; Thomas A Shaler; Ryan E Tyler; Ron R Kopito
Journal:  Nat Cell Biol       Date:  2008-02-10       Impact factor: 28.824

9.  Genetic interactions of Hrd3p and Der3p/Hrd1p with Sec61p suggest a retro-translocation complex mediating protein transport for ER degradation.

Authors:  R K Plemper; J Bordallo; P M Deak; C Taxis; R Hitt; D H Wolf
Journal:  J Cell Sci       Date:  1999-11       Impact factor: 5.285

10.  SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER.

Authors:  Britta Mueller; Brendan N Lilley; Hidde L Ploegh
Journal:  J Cell Biol       Date:  2006-10-16       Impact factor: 10.539

View more
  51 in total

1.  Selective targeting of proteins within secretory pathway for endoplasmic reticulum-associated degradation.

Authors:  Lara Vecchi; Gianluca Petris; Marco Bestagno; Oscar R Burrone
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

2.  Redundant and Antagonistic Roles of XTP3B and OS9 in Decoding Glycan and Non-glycan Degrons in ER-Associated Degradation.

Authors:  Annemieke T van der Goot; Margaret M P Pearce; Dara E Leto; Thomas A Shaler; Ron R Kopito
Journal:  Mol Cell       Date:  2018-04-26       Impact factor: 17.970

3.  Sel1L is indispensable for mammalian endoplasmic reticulum-associated degradation, endoplasmic reticulum homeostasis, and survival.

Authors:  Shengyi Sun; Guojun Shi; Xuemei Han; Adam B Francisco; Yewei Ji; Nuno Mendonça; Xiaojing Liu; Jason W Locasale; Kenneth W Simpson; Gerald E Duhamel; Sander Kersten; John R Yates; Qiaoming Long; Ling Qi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-22       Impact factor: 11.205

4.  Crystallization and preliminary X-ray diffraction analysis of the Sel1-like repeats of SEL1L.

Authors:  Hanbin Jeong; Hakbong Lee; Changwook Lee
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

5.  Characterization of protein complexes of the endoplasmic reticulum-associated degradation E3 ubiquitin ligase Hrd1.

Authors:  Jiwon Hwang; Christopher P Walczak; Thomas A Shaler; James A Olzmann; Lichao Zhang; Joshua E Elias; Ron R Kopito
Journal:  J Biol Chem       Date:  2017-04-14       Impact factor: 5.157

6.  RNF185 is a novel E3 ligase of endoplasmic reticulum-associated degradation (ERAD) that targets cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Elma El Khouri; Gwenaëlle Le Pavec; Michel B Toledano; Agnès Delaunay-Moisan
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 7.  Recent technical developments in the study of ER-associated degradation.

Authors:  Kunio Nakatsukasa; Takumi Kamura; Jeffrey L Brodsky
Journal:  Curr Opin Cell Biol       Date:  2014-05-24       Impact factor: 8.382

8.  Posttranscriptional Regulation of Glycoprotein Quality Control in the Endoplasmic Reticulum Is Controlled by the E2 Ub-Conjugating Enzyme UBC6e.

Authors:  Masatoshi Hagiwara; Jingjing Ling; Paul-Albert Koenig; Hidde L Ploegh
Journal:  Mol Cell       Date:  2016-08-25       Impact factor: 17.970

9.  Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments.

Authors:  Matthew D Shoulders; Lisa M Ryno; Joseph C Genereux; James J Moresco; Patricia G Tu; Chunlei Wu; John R Yates; Andrew I Su; Jeffery W Kelly; R Luke Wiseman
Journal:  Cell Rep       Date:  2013-04-11       Impact factor: 9.423

10.  The cytoplasmic tail of human mannosidase Man1b1 contributes to catalysis-independent quality control of misfolded alpha1-antitrypsin.

Authors:  Ashlee H Sun; John R Collette; Richard N Sifers
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.